The pricing of the offering represents a discount from the company’s recent trading price, which is a common practice in public offerings to incentivize bulk purchase by investors. However, the ...

ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the pressures to prioritize pipelines. | ...

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

Signaturefd LLC lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 172.2% in the 4th quarter, according to ...

Thrivent Financial for Lutherans lessened its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

In the wake of a disappointing market selloff, opportunities for long-term investors are emerging. History indicates that high-quality ASX 200 stocks tend to rebound, offering potential for ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and ...

Shares of Humacyte fell in post-market trading after the company said it was selling additional shares of its common stock. The biotechnology company's shares were down 20% to $2.31 following the ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...